Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Glucose–Insulin–Potassium on Metabolic and Hemodynamic Parameters During Orthotopic Liver Transplantation
IRCT20121204011662N16Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of glucose-insulin-potassium in decompensated cirrhosis, sponsored by Shiraz University of Medical Sciences. Primary endpoints: Metabolic parameters during orthotopic liver transplantation and Hemodynamic parameters during orthotopic liver transplantation. Started Oct 2024; status: completed.
02
Drugs
glucose-insulin-potassium
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on IRCT20121204011662N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121204011662N16.